Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Hatami

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Gastroenterology and Hepatology From Bed to Bench|June 14, 2019
Dietary protein sources and disease severity, malnutrition and anthropometric measurements in cirrhotic patientsFereshteh Pashayee-Khamene, Hamed Kord-Varkaneh, Mahdi Saber-Firoozi, et al.
Clinical Chemistry and Laboratory Medicine|August 31, 2022
Performance of machine learning techniques on prediction of esophageal varices grades among patients with cirrhosisAzadeh Bayani, Farkhondeh Asadi, Azamossadat Hosseini, et al.
Gastroenterology and Hepatology From Bed to Bench|February 27, 2020
Comparative study on guidelines in determining HBV phases in Iranian patientsSara Ashtari, Afsaneh Sharifian, Behzad Hatami, et al.
Clinical Chemistry and Laboratory Medicine|July 19, 2022
Identifying predictors of varices grading in patients with cirrhosis using ensemble learningAzadeh Bayani, Azamossadat Hosseini, Farkhondeh Asadi, et al.
European Journal of Medical Research|March 20, 2024
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approachesSeyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|May 8, 2023
Fibroblast growth factor 2 reduces endoplasmic reticulum stress and apoptosis in in-vitro Non-Alcoholic Fatty Liver Disease modelSeyedeh Parisa Hosseini, Shirin Farivar, Ramazan Rezaei, et al.
Gastroenterology and Hepatology From Bed to Bench|March 8, 2018
Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patientsBehzad Hatami, Sara Ashtari, Afsaneh Sharifian, et al.
Pharmacology Research & Perspectives|July 13, 2022
Fenofibrate in primary sclerosing cholangitis; a randomized, double-blind, placebo-controlled trialBehzad Hatami, Mozhde Mosala, Amir Hossein Hassani, et al.
Gastroenterology and Hepatology From Bed to Bench|September 19, 2019
Food groups intake of cirrhotic patients, comparison with the nutritional status and disease stageFereshteh Pashayee-Khamene, Mahdi Saber-Firoozi, Behzad Hatami, et al.
BMC Gastroenterology|July 27, 2019
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trialSaeede Saadati, Amir Sadeghi, Asieh Mansour, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Gastroenterology and Hepatology From Bed to Bench|June 14, 2019
Dietary protein sources and disease severity, malnutrition and anthropometric measurements in cirrhotic patientsFereshteh Pashayee-Khamene, Hamed Kord-Varkaneh, Mahdi Saber-Firoozi, et al.
Clinical Chemistry and Laboratory Medicine|August 31, 2022
Performance of machine learning techniques on prediction of esophageal varices grades among patients with cirrhosisAzadeh Bayani, Farkhondeh Asadi, Azamossadat Hosseini, et al.
Gastroenterology and Hepatology From Bed to Bench|February 27, 2020
Comparative study on guidelines in determining HBV phases in Iranian patientsSara Ashtari, Afsaneh Sharifian, Behzad Hatami, et al.
Clinical Chemistry and Laboratory Medicine|July 19, 2022
Identifying predictors of varices grading in patients with cirrhosis using ensemble learningAzadeh Bayani, Azamossadat Hosseini, Farkhondeh Asadi, et al.
European Journal of Medical Research|March 20, 2024
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approachesSeyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|May 8, 2023
Fibroblast growth factor 2 reduces endoplasmic reticulum stress and apoptosis in in-vitro Non-Alcoholic Fatty Liver Disease modelSeyedeh Parisa Hosseini, Shirin Farivar, Ramazan Rezaei, et al.
Gastroenterology and Hepatology From Bed to Bench|March 8, 2018
Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patientsBehzad Hatami, Sara Ashtari, Afsaneh Sharifian, et al.
Pharmacology Research & Perspectives|July 13, 2022
Fenofibrate in primary sclerosing cholangitis; a randomized, double-blind, placebo-controlled trialBehzad Hatami, Mozhde Mosala, Amir Hossein Hassani, et al.
Gastroenterology and Hepatology From Bed to Bench|September 19, 2019
Food groups intake of cirrhotic patients, comparison with the nutritional status and disease stageFereshteh Pashayee-Khamene, Mahdi Saber-Firoozi, Behzad Hatami, et al.
BMC Gastroenterology|July 27, 2019
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trialSaeede Saadati, Amir Sadeghi, Asieh Mansour, et al.
Pageof 9